OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Omar Emiliano Aparicio‐Trejo, et al.
Free Radical Biology and Medicine (2021) Vol. 172, pp. 65-81
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

RONS and Oxidative Stress: An Overview of Basic Concepts
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Yalith Lyzet Arancibia‐Hernández, et al.
Oxygen (2022) Vol. 2, Iss. 4, pp. 437-478
Open Access | Times Cited: 176

Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Omar Emiliano Aparicio‐Trejo, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1144-1144
Open Access | Times Cited: 137

Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2847-2892
Open Access | Times Cited: 51

Involvement of Inflammasome Components in Kidney Disease
Ana Karina Aranda‐Rivera, Anjali Srivastava, Alfredo Cruz‐Gregorio, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 246-246
Open Access | Times Cited: 41

Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, José Pedraza‐Chaverrí, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1112-1112
Open Access | Times Cited: 41

Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
Da-Wei Lin, Yung‐Chien Hsu, Cheng‐Chih Chang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6053-6053
Open Access | Times Cited: 29

Pharmacological functions of salidroside in renal diseases: facts and perspectives
Qiong Liu, Jianzhu Chen, Anqi Zeng, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 13

Schisandrin A alleviates renal fibrosis by inhibiting PKCβ and oxidative stress
Huiling Liu, Zhou Huang, Qing-Zhen Li, et al.
Phytomedicine (2024) Vol. 126, pp. 155372-155372
Closed Access | Times Cited: 9

Mitophagy induced by UMI‐77 preserves mitochondrial fitness in renal tubular epithelial cells and alleviates renal fibrosis
Lini Jin, Binfeng Yu, Guangjun Liu, et al.
The FASEB Journal (2022) Vol. 36, Iss. 6
Closed Access | Times Cited: 37

Insulin Resistance Is Cheerfully Hitched with Hypertension
Susmita Sinha, Mainul Haque
Life (2022) Vol. 12, Iss. 4, pp. 564-564
Open Access | Times Cited: 36

Roxadustat: Not just for anemia
Xiaoyu Zhu, Lili Jiang, Xuejiao Wei, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34

Sulforaphane Protects against Unilateral Ureteral Obstruction-Induced Renal Damage in Rats by Alleviating Mitochondrial and Lipid Metabolism Impairment
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Omar Emiliano Aparicio‐Trejo, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 1854-1854
Open Access | Times Cited: 29

Acteoside alleviates UUO-induced inflammation and fibrosis by regulating the HMGN1/TLR4/TREM1 signaling pathway
Yan Mao, Jiali Yu, Jingjing Da, et al.
PeerJ (2023) Vol. 11, pp. e14765-e14765
Open Access | Times Cited: 20

Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges
Fukun Chen, NaNa Chen, Chunjuan Xia, et al.
Cell Transplantation (2023) Vol. 32
Open Access | Times Cited: 19

Current Challenges of Mitochondrial Potassium Channel Research
Bogusz Kulawiak, Adam Szewczyk
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 25

The flavonoid fisetin ameliorates renal fibrosis by inhibiting SMAD3 phosphorylation, oxidative damage, and inflammation in ureteral obstructed kidney in mice
Ha Young Ju, Jongwan Kim, Sang Jun Han
Kidney Research and Clinical Practice (2023) Vol. 42, Iss. 3, pp. 325-339
Open Access | Times Cited: 16

Tet1 deficiency exacerbates oxidative stress in acute kidney injury by regulating superoxide dismutase
Fan Yu, Yangmian Yuan, Mingrui Xiong, et al.
Theranostics (2023) Vol. 13, Iss. 15, pp. 5348-5364
Open Access | Times Cited: 15

Single cell multi-omics of fibrotic kidney reveal epigenetic regulation of antioxidation and apoptosis within proximal tubule
Zhejun Chen, Liqing Ye, Minyan Zhu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5

Osthole ameliorates early diabetic kidney damage by suppressing oxidative stress, inflammation and inhibiting TGF-β1/Smads signaling pathway
Qiangsheng Li, Yifei Wang, Yan Jia, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112131-112131
Closed Access | Times Cited: 5

Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage
Xiaohua Liao, Xin Lv, Yan Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 22

Extracellular Vesicles in Redox Signaling and Metabolic Regulation in Chronic Kidney Disease
Omar Emiliano Aparicio‐Trejo, Ana Karina Aranda‐Rivera, Horacio Osorio‐Alonso, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 356-356
Open Access | Times Cited: 19

Vaccarin Ameliorates Renal Fibrosis by Inhibiting Ferroptosis via Nrf2/SLC7A11/GPX4 Signaling Pathway
Mengjiao Cui, Qiming Xu, Lianxiang Duan, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1609-1626
Open Access

Page 1 - Next Page

Scroll to top